Buels Kalmia S, Fryer Allison D
Oregon Health and Science University, 3181 SW Sam Jackson Park Road, UHN67, Portland, OR 97239, USA.
Handb Exp Pharmacol. 2012(208):317-41. doi: 10.1007/978-3-642-23274-9_14.
In healthy lungs, muscarinic receptors control smooth muscle tone, mucus secretion, vasodilation, and inflammation. In chronic obstructive pulmonary disease (COPD) and asthma, cholinergic mechanisms contribute to increased bronchoconstriction and mucus secretion that limit airflow. This chapter reviews neuronal and nonneuronal sources of acetylcholine in the lung and the expression and role of M₁, M₂, and M₃ muscarinic receptor subtypes in lung physiology. It also discusses the evidence for and against the role of parasympathetic nerves in asthma, and the current use and therapeutic potential of muscarinic receptor antagonists in COPD and asthma.
Handb Exp Pharmacol. 2012
Respir Res. 2006-5-9
Trends Pharmacol Sci. 2014-12-13
Life Sci. 2012-9-6
Handb Exp Pharmacol. 2012
Handb Exp Pharmacol. 2012
Pulm Pharmacol Ther. 2012-7-25
Handb Exp Pharmacol. 2012
Handb Exp Pharmacol. 2012
J Clin Med. 2025-7-16
Int J Mol Sci. 2024-9-24
Lung India. 2023
Proc Natl Acad Sci U S A. 2009-7-7
Naunyn Schmiedebergs Arch Pharmacol. 2009-4
N Engl J Med. 2008-10-9
J Histochem Cytochem. 2008-12